Villaseñor-Sierra A, Lomas-Bautista M, Aguilar-Benavides S, Martínez-Aguilar G

Idioma: Ingles.
Referencias bibliográficas: 14
Paginas: 330-333
Archivo PDF: 139.36 Kb.

RESUMEN

Objetivo. Identificar serotipos y susceptibilidad en cepas aisladas de 48 niños con infecciones invasivas y de 50 portadores. Material y métodos. Serotipificación mediante reacción de Quellung y susceptibilidad mediante Kirby-Bauer y E-test. Resultados. De 31 cepas meníngeas, predominaron serotipos 19F, 3, 6B, 14 y 23F y la resistencia a penicilina (P) y trimetoprim-sulfametoxazol (SXT) fue de 16 y 58%. En 17 cepas invasivas no meníngeas, predominaron serotipos 19F y 3 y la resistencia a P y SXT fue de 0 y 82%, en cada caso. En portadores predominaron serotipos 6A, 6B, 19F y 23F. Conclusiones. La resistencia es similar a otros informes. La vacuna conjugada 10-valente podría ofrecer mejor cobertura para serotipos asociados a meningitis.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002;35:547-555.

2. Di Fabio JL, Castaneda E, Agudelo CI, De La Hoz F, Hortal M, Camou T, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr Infect Dis J 2001;20:959-967.

3. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-195.

4. O’Brien KL, Shaw J, Weatherholtz R, Reid R, Watt J, Croll J, et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol 2004;160:270-278.

5. Al Mazrou A, Twum-Danso K, Al Zamil F, Kambal A. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines. Ann Saudi Med 2005;25:94-99.

6. Wasfy MO, Pimentel G, Abdel-Maksoud M, Russell KL, Barrozo CP, Klena JD, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother 2005;55:958-964.

7. Hortal M, Ruvinsky R, Rossi A, Agudelo CI, Castaneda E, Brandileone C, et al. Impact of Streptococcus pneumoniae on pneumonia in Latin American children. Sireva-Vigia Group. Rev Panam Salud Publica 2000;8:185-195.

8. Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, et al. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Pediatr Infect Dis J 2004;23:91-98.

9. Brown SD, Rybak MJ. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J Antimicrob Chemother 2004;54 Suppl 1:i7-15.

10. Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute/NCCLS. Performance Standards for antimicrobial susceptibility testing; Sixteenth Informational Supplement. CLSI/NCCLS document M100-S16. Ninth Edition. Wayne, PA: Clinical and Laboratory Standards Institute/NCCLS, 2006.

11. Lauderdale TL, Wagener MM, Lin HM, Huang IF, Lee WY, Hseih KS, et al. Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates. Diagn Microbiol Infect Dis 2006;56:421-426.

12. Stratchounski LS, Kretchikova OI, Kozlov RS, Reshedko GK, Stetsiouk OU, Tarasova GD, et al. Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia. Pediatr Infect Dis J 2000;19:196-200.

13. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-1792.

14. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-1729.